Josh Waitzman's Avatar

Josh Waitzman

@jwaitz.bsky.social

Kidney doc, biochemist, and dad, taking life one kinesin-sized step at a time. He/him. Employed by Vertex Pharmaceuticals | BIDMC Nephrology | opinions my own

1,233 Followers  |  798 Following  |  208 Posts  |  Joined: 09.11.2024  |  2.603

Latest posts by jwaitz.bsky.social on Bluesky

Preview
Immune tolerance in kidney transplantation: from first principles to clinical engineering โ€” NephJC A commentary putting the chimerism and immune tolerance in perspective

Perhaps we can help! Great commentary by @nephroseeker.bsky.social

www.nephjc.com/news/2025/30...

06.10.2025 13:16 โ€” ๐Ÿ‘ 0    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases Nature Reviews Immunology - In this Review, the authors discuss the origins of regulatory T (Treg) cells in the periphery and the mechanisms by which Treg cells are induced, as well as the...

rdcu.be/eJHTr

rdcu.be/eJHU8

www.sciencedirect.com/science/arti...

www.annualreviews.org/content/jour...

06.10.2025 13:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

I guess this means itโ€™s time for me to try to understand what Tregs doโ€ฆ

(Thanks @enirenberg.bsky.social for the great explainer!)

06.10.2025 13:10 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0
Preview
PARASOL Project Expands Focus to APOL1, Membranous Nephropathy PARASOL Project expands to focus on APOL1 kidney disease and primary membranous nephropathy, aiming to improve clinical trial endpoints for these conditions.

PARASOL Project is expanding focus to include biomarkers & endpoints in APOL1 kidney disease and primary MN as well as FSGS. Learn more: eu1.hubs.ly/H0nr8Lv0
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social

03.10.2025 13:26 โ€” ๐Ÿ‘ 5    ๐Ÿ” 4    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1
Dark Teal background with white circle in middle with yellow border. In the circle it says C3G Awareness Day. Under the circle there is a hashtag #C3GAwarenessDay, and the text Every rare kidney disease deserves to be seen.

Dark Teal background with white circle in middle with yellow border. In the circle it says C3G Awareness Day. Under the circle there is a hashtag #C3GAwarenessDay, and the text Every rare kidney disease deserves to be seen.

Today is #C3GAwarenessDay! At ISGD, we stand with people living with this rare kidney disease. As a medical society for #GlomerularDisease experts, we're committed to raising awareness and moving the science forward to bring more hope and solutions to the C3G community. #C3G #ISGD

25.09.2025 15:34 โ€” ๐Ÿ‘ 3    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Excellent thread below

I will also plug this talk by Paola Romagnani on podocytopathies

youtu.be/bRMeqaGgA9I?...

#GlomCon #NephGR

24.09.2025 00:00 โ€” ๐Ÿ‘ 11    ๐Ÿ” 5    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
a man holding a note that says welcome ta baahstun on it ALT: a man holding a note that says welcome ta baahstun on it
24.09.2025 01:49 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Agree 100% that maintenance dialysis pts and post transplant pts deserve better quality of evidence than we have.
#nephjc

17.09.2025 02:02 โ€” ๐Ÿ‘ 6    ๐Ÿ” 1    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

Peopleโ€™s practice habits are so hard-wired in training.
Lisinopril and losartan are still the most prescribed ACEi and ARB.
#nephjc

17.09.2025 02:00 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Thanks for a great discussion! #nephjc

17.09.2025 01:59 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
a woman is holding a red megaphone in front of her mouth Alt: a woman is holding a red megaphone in front of her mouth

#nephjc

17.09.2025 01:56 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Right: more aldo, more combo meds, advocating for GLP1 as part of lifestyle change
Wrong: 130=/=120, even stronger aldo rec, even stronger GLP1 rec so that insurance will cover it
#nephjc

17.09.2025 01:57 โ€” ๐Ÿ‘ 8    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

If someone figures out how to change nephrology practice, please let me know #nephjc

17.09.2025 01:54 โ€” ๐Ÿ‘ 5    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Cognitive impairment data

Cognitive impairment data

Yes! Slide care of Paul Whelton at this yearโ€™s #Hypertension25

#nephjc

17.09.2025 01:50 โ€” ๐Ÿ‘ 6    ๐Ÿ” 5    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

If someone feels bad on multiple different agents tried serially to get them below 140 thatโ€™s a special case.

I do wonder if thereโ€™s an argument to look for carotid stenosis or similar in patients like this.

#nephjc

17.09.2025 01:51 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Yes. I worry weโ€™ve told folks โ€œold people can ride higherโ€ for a long time, and itโ€™s fighting a lot of therapeutic inertia to target a lower BPs goal to prevent dementia.

#nephjc

17.09.2025 01:49 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
a close up of a man 's face with his mouth open . ALT: a close up of a man 's face with his mouth open .

MORE!

And by MORE! I mean LESS (systolic BP)

#nephjc

17.09.2025 01:42 โ€” ๐Ÿ‘ 6    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
a man in a pink jacket drinks from a wine glass ALT: a man in a pink jacket drinks from a wine glass

But each has benefits like a fine wine:

-The uric acid lowering of losartan

-The longest half life of telmisartan

-The bonus migraine prophylaxis of candesartan

#nephjc

17.09.2025 01:40 โ€” ๐Ÿ‘ 8    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
a cartoon of two halves of toast with the words me and you were the perfect match ALT: a cartoon of two halves of toast with the words me and you were the perfect match

Love the spotlight that combo agents get here.

#nephjc

17.09.2025 01:38 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
a woman wearing a crown and a gold dress is asking what 's not to love . ALT: a woman wearing a crown and a gold dress is asking what 's not to love .

Olmesartanโ€™s more effective and comes in a combo w amlodipine.

pmc.ncbi.nlm.nih.gov/articles/PMC...

#nephjc

17.09.2025 01:37 โ€” ๐Ÿ‘ 7    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

I still wonderโ€”does it need to be this complicated for BP?

Why not double down on the 120 systolic goal for everyone and leave the slide rule for statins?

#nephjc

17.09.2025 01:32 โ€” ๐Ÿ‘ 6    ๐Ÿ” 0    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

Reposting a q I had re the lower treatment threshold/goal for #nephjc

17.09.2025 01:30 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Or, per endo society guideline, ALL individuals w HTN

academic.oup.com/jcem/article...

#nephjc

17.09.2025 01:27 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
three men in mariachi outfits stand in a line ALT: three men in mariachi outfits stand in a line

#nephjc

17.09.2025 01:23 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
a woman in a red suit is holding a microphone ALT: a woman in a red suit is holding a microphone

Renin/Aldo? Per the new endo guidelines, every hypertensive pt should get one.
#nephjc

17.09.2025 01:22 โ€” ๐Ÿ‘ 5    ๐Ÿ” 0    ๐Ÿ’ฌ 3    ๐Ÿ“Œ 0
Preview
a cartoon of spongebob making a face with his hands Alt: a cartoon of spongebob making a face with his hands saying job security

#nephjc

17.09.2025 01:19 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

All the randomized trial data is to a target of 120 systolic.

I still like the KDIGO guideline attitudeโ€”just because we are all terrible at measuring BP, it doesnโ€™t mean we should add a fudge factor for bad measurement. It means we should measure better.

#nephjc

17.09.2025 01:16 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

AUTHOR IN THE HOUSE!! #nephjc

17.09.2025 01:09 โ€” ๐Ÿ‘ 10    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Josh Waitzmanโ€”I work for Vertex and BIDMC.
I like lower BPs and I cannot lie
#nephjc

17.09.2025 01:04 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
a man stands in front of a dragon statue ALT: a man stands in front of a dragon statue

Yeah, but shouldnโ€™t target take the center stage? #nephjc

17.09.2025 01:02 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

@jwaitz is following 19 prominent accounts